Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease

BACKGROUND: Diabetic patients present with an accelerated atherosclerotic process and an increased risk for future cardiovascular events. In addition to the risk imposed by the disease itself, pharmacological treatment adds also a sizable risk, especially if certain classes of antidiabetic drugs are...

Descripción completa

Detalles Bibliográficos
Autores principales: Klempfner, Robert, Leor, Jonathan, Tenenbaum, Alexander, Fisman, Enrique Z, Goldenberg, Ilan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403890/
https://www.ncbi.nlm.nih.gov/pubmed/22672501
http://dx.doi.org/10.1186/1475-2840-11-60

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403890/
https://www.ncbi.nlm.nih.gov/pubmed/22672501
http://dx.doi.org/10.1186/1475-2840-11-60

Ejemplares similares